Gene · 1645
Papers1,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progesterone inactivation in decidual stromal cells: A mechanism for inflammation-induced parturition. | Proc Natl Acad Sci U S A | 2024 | 38861608 | PubTator, text mining | PubMed |
| A data decomposition-based hierarchical classification method for multi-label classification of contractual obligations for the purpose of their governance. | Sci Rep | 2024 | 38830999 | PubTator, text mining | PubMed |
| Targeting KPNB1 with genkwadaphnin suppresses gastric cancer progression through the Nur77-mediated signaling pathway. | Eur J Pharmacol | 2024 | 38823760 | PubTator, text mining | PubMed |
| COVID-19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples. | Br J Clin Pharmacol | 2024 | 38817198 | PubTator, text mining | PubMed |
| Conditional disruption of Nr5a1 directed by Sox9-Cre impairs adrenal development. | Sci Rep | 2024 | 38811798 | PubTator, text mining | PubMed |
| Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types. | Nat Commun | 2024 | 38744958 | PubTator, text mining | PubMed |
| Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader. | Commun Chem | 2024 | 38684887 | PubTator, text mining | PubMed |
| Author Correction: Aldo-keto reductase 1C2 (AKR1C2) as the second gene associated to non-syndromic primary lipedema: investigating activating mutation or overexpression as causative factors. | Eur Rev Med Pharmacol Sci | 2024 | 38567622 | PubTator, text mining | PubMed |
| Research on the dynamic behavior of flexible drilling tools in ultrashort-radius radial horizontal wells. | Sci Rep | 2024 | 38538686 | PubTator, text mining | PubMed |
| NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence. | Cell Death Discov | 2024 | 38472205 | PubTator, text mining | PubMed |
| A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma. | Am J Cancer Res | 2024 | 38323276 | PubTator, text mining | PubMed |
| Outcomes of antiretroviral treatment for 0-14-year-old children living with HIV in Ganzhou, China, 2006-2023. | AIDS Res Ther | 2024 | 38297382 | PubTator, text mining | PubMed |
| Identification of novel biomarkers of ferroptosis involved in keloid based on bioinformatics analysis. | Int Wound J | 2024 | 38272797 | PubTator, text mining | PubMed |
| Single cell multi-omics of fibrotic kidney reveal epigenetic regulation of antioxidation and apoptosis within proximal tubule. | Cell Mol Life Sci | 2024 | 38270638 | PubTator, text mining | PubMed |
| The Apical Endocytic-Lysosomal Apparatus in CLCN5 Mutations with Phenotypic-Genotypic Correlations in Three Cases. | Int J Mol Sci | 2024 | 38256038 | PubTator, text mining | PubMed |
| Omics Studies of Tumor Cells under Microgravity Conditions. | Int J Mol Sci | 2024 | 38255998 | PubTator, text mining | PubMed |
| Introducing the f0% method: a reliable and accurate approach for qPCR analysis. | BMC Bioinformatics | 2024 | 38212692 | PubTator, text mining | PubMed |
| Angular dihydropyranocoumarins from the flowers of Peucedanum japonicum and their aldo-keto reductase inhibitory activities. | Phytochemistry | 2024 | 38211847 | PubTator, text mining | PubMed |
| BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer. | Cell Death Discov | 2024 | 38182557 | PubTator, text mining | PubMed |
| Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer. | Oncoimmunology | 2024 | 38170044 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1645/papers?page=6